3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
5
Phase 2
4
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 1
1
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Interventions
Cisplatin
13
Paclitaxel
11
Cyclophosphamide
11
Doxorubicin
10
Magnetic Resonance Spectroscopy
9
Gemcitabine
9
Prednisone
8
Docetaxel
8
Specimen Handling
7
Oxaliplatin
7
Carboplatin
7
Vincristine
6
Etoposide
6
Capecitabine
6
pembrolizumab
5
Rituximab
5
Radiotherapy
5
Leucovorin
5
Cytarabine
5
Bevacizumab
5
atezolizumab
4
Trastuzumab
4
Platinum
4
Nivolumab
4
Fluorouracil
4
Dexamethasone
4
Biopsy
4
1,2-diaminocyclohexaneplatinum II citrate
4
Watchful Waiting
3
Taxes
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Active not recruiting
×
abiraterone
×
Clear all
NCT00268476
2023-04-18
STAMPEDE
Medical Research Council
Phase 2/3
Active not recruiting
11,992 enrolled